Healthcare -
Biotechnology - NASDAQ - US
$ 0.82
-1.2 %
$ 5.31 M
Market Cap
-0.28
P/E
ADIL - COST OF REVENUE
Cost of Revenue ADIL - Adial Pharmaceuticals, Inc.
564
LAST VALUE
-89.88%
2 YEAR CAGR
0.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR